Richard Segiel, Jr. Joins Almac as Vice President of US Business Development
October 29, 2013
Almac’s Clinical Services Business Unit is delighted to announce that Richard Segiel, Jr. has joined the company as Vice President of Business Development for the United States. He brings with him 23 successful years of experience in the contract pharmaceutical development sector. In his new role, he will focus on developing new business, maintaining existing business, and developing partnerships.
Prior to joining Almac, Richard held a number of Business Development and Operational positions at Intertek Pharmaceutical Services, MDS Tricon, Celsis Analytical Services, and Pharmakon Research International.
“Richard brings a compelling mix of business development, operational, and financial experience that will further strengthen Almac’s leadership team. This skill set is key to delivering on our core objective of enhancing our US client relationships, further developing our commitment to customer service, and helping achieve true strategic partnerships,” said Martin Lamb, Global VP of Business Development.
Most recently, Richard served as Business Development Director of Intertek Pharmaceutical Services where he had direct responsibility for all Business Development and Sales initiatives for the company’s Chemical and Pharmaceutical Division NA.
As Vice President, Business Development at Celsis Analytical Services, Richard assembled the sales and client services divisions, which achieved record sales performance for six consecutive years under his supervision. Additionally, Richard implemented many sales infrastructure programs including the organization’s first CRM system, new KPI metrics, as well as successful sales compensation plans.
“We are very pleased to have Richard on our growing Business Development team. Richard’s experience in the contract pharmaceutical development sector coupled with his proven ability to develop, build, and manage a world-class sales force will make him a vital asset to our team,” says Robert Dunlop, President of Almac’s Clinical Services Business Unit. “Our goal was to find a proven leader who could help us grow our business in the US, and Richard is the perfect fit.”
Richard holds a bachelor’s degree in Chemistry and Business from the University of Scranton and an MBA in Marketing and Finance. Richard lives in Gouldsboro, Pennsylvania with his wife Kimarie and their two children.
‘Partnering to Advance Human Health’
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to over 600 companies globally within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over 30 years and now employs in excess of 3,300 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with US operations based in Pennsylvania, North Carolina and California.